adenosine monophosphate has been researched along with Heart Diseases in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (46.67) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 5 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Brondeel, KC; Charipova, K; Cornett, EM; Erwin, A; Fox, CJ; Gress, KL; Kaye, AD; Kevil, CG; Knight, HE; Lerner, ZI; Urits, I; Urman, RD | 1 |
| Arthur, CM; Clarke, S; Josephson, CD; Lough, C; MacDonald, H; Roback, JD; Rodriguez, Z; Shane, AL; Stowell, SR; Suthar, M; Verkerke, H; Wolf, M; Wrammert, J; Zimmerman, MG | 1 |
| Aslan, GS; Bojkova, D; Ciesek, S; Cinatl, J; Dendorfer, A; Dimmeler, S; Ermel, UH; Eschenhagen, T; Frangakis, AS; Günther, S; Hansen, A; Harter, PN; Klingel, K; Krishnan, J; Luxán, G; Milting, H; Pham, MD; Saleem, U; Shumliakivska, M; Tschöpe, C; Wagner, JUG; Zeiher, AM | 1 |
| Ban, K; Choi, SW; Go, YY; Jung, E; Kim, SJ; Lee, J; Lee, JH; Moon, SH; Park, HJ; Park, SJ; Park, SM; Park, YG; Shin, JS | 1 |
| Khaheshi, I; Shahrbaf, MA; Tabary, M | 1 |
| Abtan, J; Bhatt, DL; Deliargyris, EN; Ducrocq, G; Elkin, S; Gibson, CM; Hamm, C; Harrington, RA; Mahaffey, KW; Menozzi, A; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD | 1 |
| GRUND, G; OLIVET, J | 1 |
| VOGEL, G | 1 |
| BOSCHI, F; RANCATI, E | 1 |
| Aussedat, J; Lavanchy, N; Rossi, A | 1 |
| Obata, T | 1 |
| Clanachan, AS; Finegan, BA | 1 |
| Abd-Elfattah, AS; Brunsting, LA; Goldstein, JP; Murphy, CE; Salter, DR; Wechsler, AS | 1 |
| DiPalma, JR | 1 |
| Hall, A; Hauschildt, S; Olson, RE; Tan, CH | 1 |
4 review(s) available for adenosine monophosphate and Heart Diseases
| Article | Year |
|---|---|
Biology of COVID-19 and related viruses: Epidemiology, signs, symptoms, diagnosis, and treatment.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Animals; Antiviral Agents; Coronavirus; Cough; COVID-19; Diabetes Mellitus; Fatigue; Fever; Heart Diseases; Humans; Positive-Pressure Respiration; Prognosis; Pulmonary Disease, Chronic Obstructive; SARS-CoV-2; Treatment Outcome | 2021 |
[Physiopathologic modifications in the myocardial levels of adenine nucleotides].
Topics: Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Cardiomegaly; Coronary Disease; Creatine Kinase; Energy Metabolism; Energy Transfer; Heart Diseases; Humans; Kinetics; Models, Biological; Myocardium | 1984 |
[In vivo microdialysis technique on rat myocardium].
Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Calcium Channels; Heart Diseases; Hydroxyl Radical; Microdialysis; Myocardium; Perfusion; Rats | 2001 |
Myocardial protection.
Topics: Adenosine Monophosphate; Animals; Antioxidants; Buffers; Calcium Channel Blockers; Cardiac Surgical Procedures; Cardioplegic Solutions; Citric Acid Cycle; Coronary Circulation; Diastole; Free Radicals; Heart; Heart Arrest, Induced; Heart Diseases; Heart Injuries; Humans; Hypothermia, Induced; Infant, Newborn; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Oxygen; Oxygen Consumption; Time Factors | 1986 |
1 trial(s) available for adenosine monophosphate and Heart Diseases
| Article | Year |
|---|---|
Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trial.
Topics: Adenosine Monophosphate; Aged; Double-Blind Method; Female; Heart Diseases; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; ST Elevation Myocardial Infarction; Thrombosis; Treatment Outcome | 2019 |
10 other study(ies) available for adenosine monophosphate and Heart Diseases
| Article | Year |
|---|---|
COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Neutralizing; Antiviral Agents; Coronavirus Infections; COVID-19; Down Syndrome; Female; Heart Diseases; Humans; Immunization, Passive; Infant; Pandemics; Pneumonia, Viral; Respiratory Insufficiency | 2020 |
SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes.
Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Apoptosis; Caco-2 Cells; Cathepsins; COVID-19; COVID-19 Drug Treatment; Heart Diseases; Host-Pathogen Interactions; Humans; Myocytes, Cardiac; Reactive Oxygen Species; SARS-CoV-2; Signal Transduction | 2020 |
Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes.
Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antimalarials; Antiviral Agents; Chlorocebus aethiops; Chloroquine; COVID-19; COVID-19 Drug Treatment; Electrocardiography; Flow Cytometry; Heart Diseases; Humans; Hydroxychloroquine; Microscopy, Fluorescence; Myocytes, Cardiac; Pluripotent Stem Cells; Pyrazines; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Vero Cells; Viral Plaque Assay | 2020 |
Cardiovascular Considerations of Remdesivir and Favipiravir in the Treatment of COVID-19.
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; COVID-19 Drug Treatment; Heart Diseases; Humans; Pyrazines; SARS-CoV-2 | 2021 |
[Heart therapy with adenylic acid].
Topics: Adenosine Monophosphate; Cardiotonic Agents; Glycosides; Heart Diseases; Nucleotides | 1953 |
[Adenylic acid system in the blood in heart diseases].
Topics: Adenosine Monophosphate; Heart; Heart Diseases; Hematologic Diseases; Nucleosides; Nucleotides | 1958 |
[Clinical experiences on the therapeutic action of the association AMP-cocarboxylase-vitamin B 12 in dysmetabolic heart disease in the course of pulmonary tuberculosis].
Topics: Adenine Nucleotides; Adenosine Monophosphate; Heart Diseases; Humans; Pulmonary Heart Disease; Thiamine Pyrophosphate; Tuberculosis; Tuberculosis, Pulmonary; Vitamin B 12 | 1963 |
Comparison of the haemodynamic effects of adenosine monophosphate with sodium nitroprusside in a canine model of acute global left ventricular dysfunction.
Topics: Adenosine Monophosphate; Anesthesia; Animals; Blood Pressure; Cardiac Output; Coronary Vessels; Dogs; Female; Heart Diseases; Heart Rate; Heart Ventricles; Hemodynamics; Male; Nitroprusside; Vasodilation; Ventricular Function, Left | 1991 |
Histamine H2 receptor antagonists.
Topics: Adenosine Monophosphate; Agranulocytosis; Anaphylaxis; Animals; Antigens; Blood Pressure; Cats; Chemoreceptor Cells; Chlorpheniramine; Dogs; Gastric Juice; Guinea Pigs; Heart Diseases; Histamine; Histamine H1 Antagonists; Humans; Hypersensitivity; Leukocytes; Penicillins | 1974 |
The effect of thiamine deficiency upon the contractility and metabolism of the isolated perfused rat heart.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animal Nutritional Physiological Phenomena; Animals; Citric Acid Cycle; Dose-Response Relationship, Drug; Glyoxylates; Heart; Heart Diseases; Lactates; Male; Myocardium; Oxidoreductases; Perfusion; Phosphocreatine; Pyruvates; Rats; Thiamine Deficiency; Tricarboxylic Acids | 1973 |